PN

Pranesh Narayan Mallaya

Director Director DIN 09075976
DIN 09075976 First appointment Apr 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2020
Shareholding value •••• Premium profile

About Pranesh Narayan Mallaya

Data last updated:

Pranesh Narayan Mallaya was a Director at Atul Lifescience Limited (2021–2023) and Cfo at Atul Bioscience Limited (2020–2021). The companies operate in Pharma.

DIN 09075976
Primary Designation Director
Industry Pharma
First Appointment 24 Apr 2020

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Atul Lifescience Limited U24290GJ2021PLC120451
Director22 Feb 20212021₹76,690 (FY 2025)Active
Atul Bioscience Limited U24230GJ1997PLC032369
Cfo24 Apr 20201997₹137 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Atul Lifescience Limited
Atul Bioscience Limited
Premium access

Shareholding and investment profile for Pranesh Narayan Mallaya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pranesh Narayan Mallaya

Pranesh Narayan Mallaya was first appointed on 24 Apr 2020 as Cfo at Atul Bioscience Limited. The most recent appointment on record is 22 Feb 2021 at Atul Lifescience Limited.

Pranesh Narayan Mallaya held 2 earlier board appointments: Atul Lifescience Limited (Director, 22 Feb 2021 to 05 Oct 2023); Atul Bioscience Limited (Cfo, 24 Apr 2020 to 22 Oct 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available